EphA2 siRNA treatment suppressed the cellular invasion in the non-metastatic RCC cell lines (Caki-2 and A498) (Fig 6B and 6C), but not in the metastatic RCC cell lines (Caki-1 or ACHN) (Fig 6A and 6C). The gene discussed is EPHA2; the disease is renal cell carcinoma.